CSF2 and COVID-19: A growing body of literature suggests that IL-17 and GM-CSF levels are elevated in the peripheral blood of patients with COVID-19 and that the proportion of Th17 cells in the bronchoalveolar lavage fluid is significantly elevated in these patients [132].